8-K
filed July 11, 2023, 7:59 PM ET
ticker NVAX
CIK 0001000694
other material
confidence high
sentiment neutral
materiality 0.50
Novavax stockholders approve 6.17M share increase under Amended 2015 Stock Plan
NOVAVAX INC
- Proposal 5 approved: Amended 2015 Stock Plan with 15.1M for, 3.8M against; adds 6,170,000 authorized shares.
- Proposal 4 failed: officer exculpation charter amendment received 16.7M for, 2.1M against, but not approved.
- Directors elected: John C. Jacobs (18.1M for), Gregg H. Alton (11.3M for), Richard J. Rodgers (13.1M for).
- Advisory say-on-pay approved (15.7M for); frequency set at one year (17.8M for one-year option).
- Ratification of Ernst & Young as auditor passed with 41.4M for, 2.0M against.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
NOVAVAX INC shareholders approved Advisory vote on the frequency of future named executive officer compensation votes at the 2023-07-11 meeting.
- Proposal
- say on pay frequency
- Outcome
- passed
- Meeting
- 2023-07-11
Exact text from the filing
Proposal 3 : Stockholders approved, on an advisory basis, the frequency of future named executive officer compensation votes: One Year Two Years Three Years Abstaining Broker Non-Votes 17,803,121 342,423 846,988 271,533 24,476,819
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
NOVAVAX INC shareholders approved Amendment and restatement of the Novavax Inc. Amended and Restated 2015 Stock Incentive Plan to increase the number of shares available for issuance by 6,170,000 at the 2023-07-11 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2023-07-11
Exact text from the filing
Proposal 5 : Stockholders approved the amendment and restatement of the Novavax Inc. Amended and Restated 2015 Stock Incentive Plan to increase the number of shares of Common Stock available for issuance thereunder by 6,170,000 shares: For Against Abstaining Broker Non-Votes 15,131,768 3,824,183 308,114 24,476,819
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
NOVAVAX INC shareholders approved Election of Class I nominees for director at the 2023-07-11 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-07-11
Exact text from the filing
Proposal 1 : Stockholders elected the following Class I nominees for director, each to serve a three-year term expiring at the 2026 Annual Meeting of Stockholders: Name For Against Abstain Broker Non-Votes John C. Jacobs 18,096,901 881,806 285,358 24,476,819 Gregg H. Alton, J.D. 11,319,429 7,498,303 446,333 24,476,819 Richard J. Rodgers 13,138,940 5,662,283 462,842 24,476,819
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
NOVAVAX INC shareholders rejected Amendment to the Second Amended and Restated Certificate of Incorporation to reflect Delaware law provisions allowing officer exculpation at the 2023-07-11 meeting.
- Proposal
- charter amendment
- Outcome
- failed
- Meeting
- 2023-07-11
Exact text from the filing
Proposal 4 : Stockholders did not approve the amendment to the Second Amended and Restated Certificate of Incorporation of Novavax, Inc. to reflect Delaware law provisions allowing officer exculpation: For Against Abstaining Broker Non-Votes 16,746,786 2,058,948 458,331 24,476,819
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
NOVAVAX INC shareholders approved Advisory vote on the compensation paid to the Company’s named executive officers in 2022 at the 2023-07-11 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-07-11
Exact text from the filing
Proposal 2 : Stockholders approved, on an advisory basis, the compensation paid to the Company’s named executive officers in 2022: For Against Abstaining Broker Non-Votes 15,695,578 3,030,052 538,435 24,476,819
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
NOVAVAX INC shareholders approved Ratification of appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-07-11 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-07-11
Exact text from the filing
Proposal 6 : Stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023: For Against Abstaining Broker Non-Votes 41,350,254 2,005,826 384,804 —
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.